When you're recruiting physicians, nurses or allied health professionals, ElsevierHealthCareers.com is a great place to start. Why? Because no other healthcare recruitment site has the global reach and deep roots in the world's healthcare communities that Elsevier can offer you as the publisher of 2,000 journals, 19,000 books and numerous websites dedicated to every branch of healthcare. Post jobs. Search and purchase resumes. Showcase your company, quickly and efficiently. Reach millions of physicians, nurses and allied health professionals worldwide.

In the quest to find qualified candidates, ElsevierHealthCareers.com is a powerful partner.

www.elsevierhealthcareers.com

Media Contact:
Andrew Berin
Elsevier
+1 212 633 3887
a.berin@elsevier.com

New York, 16 November 2009 - Elsevier is pleased to announce that beginning with Volume 104 (2010) it will assume publication of the Annals of Allergy, Asthma & Immunology, the official journal of the American College of Allergy, Asthma & Immunology (ACAAI). 

The Annals of Allergy, Asthma & Immunology, published since 1942, will continue under the leadership of Editor Gailen D. Marshall, MD, PhD and a distinguished editorial board.  The journal provides solid, peer-reviewed coverage of current clinical science (both research and practice-based) that is readily applicable to both the clinician and the researcher in the fields of allergy, asthma, and immunology.  Each monthly issue also provide opportunities to participate in accredited continuing medical education activities to enhance overall clinical proficiency.
Andrew Berin, Health Sciences Publisher, commented, "Elsevier is delighted to add Annals of Allergy, Asthma & Immunology to our publishing program.  Working in partnership with the Editor, Editorial Board and the American College of Allergy, Asthma & Immunology, our goal is to continue to underscore the journal's mission of providing research and clinically relevant information to the widest possible audience of practicing allergists and immunologists."
 
Dr. Marshall stated, "We, at Annals, are pleased to have entered into this partnership with the largest and most respected publishing house in the fields of science and medicine.  Our intent is to continue to strive for excellence and relevance.  Our Board and the College are excited by the possibilities."

Annals of Allergy, Asthma and Immunology (current and archived issues) will be available for purchase via Journals Consult (powered by ScienceDirect).

Media Contact:
Anthony Trioli
Elsevier
+1 215 239 3733
a.trioli@elsevier.com

Philadelphia, PA, 4 November 2009 – Elsevier, world-leading publisher of scientific, technical and medical information products and services, is pleased to announce that beginning in January 2010 (Volume 93, Issue 1) it will assume co-publication of the Journal of Dairy Science, the official journal of the American Dairy Science Association (ADSA®), with the Federation of Animal Science Societies (FASS).

Established in 1917, the Journal of Dairy Science (JDS) is a monthly peer-reviewed publication featuring original research and review articles that present the latest scientific and technical findings. It covers dairy foods; physiology and management; nutrition, feeding and calves; and genetics and breeding. JDS is currently the top-ranked general dairy research journal in the world. With an Impact Factor of 2.486 and a 5-year Impact Factor of 2.978, according to the 2009 Journal Citation Reports®, JDS ranks first (of 45 titles) in the agriculture, dairy and animal science category. JDS is also ranked as the number 1 journal in the category by Eigenfactor score.

According to Anthony F. Trioli, Publisher, Health Sciences Journals at Elsevier, “We are extremely pleased to add the Journal of Dairy Science, the most highly ranked journal in its field, to our animal science publishing portfolio. Working in partnership with the editor-in-chief, the JDS editorial board and ADSA, our goal is to extend the journal’s reach both in the United States and abroad.”
Journal of Dairy Science (current and archived issues) will be available for purchase via Journals Consult (powered by ScienceDirect).

Media Contact:
Jayne Dawkins
Elsevier
+1 215 239 3674
Ja.dawkins@elsevier.com

New York, 21 October 2009– Elsevier is pleased to announce that beginning with Volume 49, Number 1 (January 2010) it will assume publication of the Journal of the American Academy of Child & Adolescent Psychiatry, official publication of the American Academy of Child and Adolescent Psychiatry (AACAP).

According to Josh Spieler, Health Sciences Publisher, “Elsevier is delighted to add the Journal of the American Academy of Child & Adolescent Psychiatry, the most highly regarded peer-reviewed journal in its field, to our publishing portfolio. Working with the Editor-in-Chief, editorial board, and the AACAP, our intent is to extend the reach of the journal, both domestically and internationally, and to support the translation of scientific discovery into improved patient care."

As it enters its 49th year of publication, the Journal of the American Academy of Child & Adolescent Psychiatry will continue under the leadership of Editor-in-Chief Andrés Martin, M.D., M.P.H. and its distinguished editorial board. The journal provides cutting-edge, peer-reviewed scientific content on all aspects relevant to child and adolescent mental health Each monthly issue will also provide opportunities to participate in accredited continuing medical education activities to enhance overall clinical proficiency.
Editor-in-Chief Andrés Martin, M.D., M.P.H stated, “We are pleased to have entered into this partnership with the largest and most respected publishing house in the field of science and medicine."

Journal of the American Academy of Child & Adolescent Psychiatry (current and archived issues) will be available for purchase via Journals Consult (powered by ScienceDirect).

Media Contact:
Lynelle Korte
Elsevier
+1 314 453 4841
l.korte@elsevier.com

St. Louis, MO, 9 September 2009 – Elsevier, world-leading publisher of scientific, technical and medical information products and services, is pleased to announce a new publishing partnership with the Canadian College of Health Service Executives (CCHSE). The College’s official journal, Healthcare Management Forum (HMF), will be published by Elsevier beginning in 2010.

Launched in 1988, Healthcare Management Forum is a trusted resource for innovative solutions and leading practices related to health leadership. Widely recognized for its high-quality contributions and rigorous review process, HMF serves the needs of a diverse and changing health leadership community by linking scholarly inquiry with new ways of thinking about professional practice.
Managing Editor, Laurie Wilson, commented, “We are delighted about this new relationship. Working with Elsevier, HMF will continue to thrive and expand as a forum for information exchange about vital topics in the field, to the benefit of both our authors and readership.”

An eminent Editorial Board is led by Editor-in-Chief Kevin Mercer, FCCHSE, District Manager of ParaMed Home Health Care. “One of the primary goals of our journal is to guide decision-making at the highest levels,” stated Mercer. “In today’s healthcare environment, senior leaders must have the skills and experience to translate knowledge into action. They need to know about the latest developments to foster innovation and support staff. The Editorial Board and I look forward to working with Elsevier to communicate this critical information to the widest possible audience.”

Healthcare Management Forum publishes four times annually with issues appearing in April, July, October and December. Elsevier will begin publication with Volume 23 (2010). Several sections of front matter, the featured article and all abstracts will appear in English and French. The Journal is currently indexed and abstracted in MEDLINE and PubMed.

Healthcare Management Forum (current and archived issues) will be available for purchase via Journals Consult (powered by ScienceDirect).

 

Media Contact:
Lynelle Korte
Elsevier
+1 314 453 4841
l.korte@elsevier.com

London, 14 July 2009 - Elsevier, a world-leading publisher of scientific, technical and medical information products and services, is pleased to announce the formation of a publishing partnership with   The Royal College of Surgeons of Edinburgh and   The Royal College of Surgeons in Ireland. Under the agreement, Elsevier will assume publication of The Surgeon, the official journal of these prestigious Royal Colleges, from January 2010.

The Surgeon is published for 18,000 Members and Fellows of both Colleges and also the worldwide surgical community. It contains articles from surgery, dentistry and related specialties and aims to educate, entertain, give insight into new techniques and technology, and provide a forum for debate and discussion. With its regular sections including original articles, reviews and debates, The Surgeon is a must-read for senior practitioners and trainees alike.

Professor Austin Leahy, Editor-in-Chief, said: “The Royal College of Surgeons of Edinburgh and the Royal College of Surgeons in Ireland are excited by the agreement with Elsevier to publish The Surgeon. This will enable the journal to reach a wider audience of surgical specialists across the world, therefore strengthening the reputation of the journal. The journal content will be printed at a faster pace and will also be accessible electronically sooner after acceptance. In addition, the submission and the reviewing of all manuscripts will be web-based, supported by Elsevier’s online submission system. This new procedure, which will be implemented shortly, will drastically reduce the reviewing turnaround time and will therefore encourage more authors to submit their best work to the journal.”

The Surgeon (current and archived issues) will be available for purchase via Journals Consult (powered by ScienceDirect).

Media Contact:
Herb Niemirow, Publisher
Elsevier
212-633-3141
h.niemirow@elsevier.com

PM&R Accepted for Abstracting and Indexing in MEDLINE®

Philadelphia, PA, July 8, 2009 – Elsevier, a world-leading publisher of scientific, technical and medical information products and services, is pleased to announce that PM&R -The journal of injury, function and rehabilitation (www.pmrjournal.org), the official scientific journal of the American Academy of Physical Medicine and Rehabilitation (AAPM&R), has been accepted for coverage by MEDLINE, just six
months after its launch in January 2009. Under the guidance of Editor-in-Chief Stuart M. Weinstein, MD, Clinical Professor of Rehabilitation Medicine at the University of Washington, Seattle, and an internationally renowned Editorial Board, this monthly, peer-reviewed, scholarly publication has a clinical focus, presenting an array of topics pertinent to physiatrists (rehabilitation medicine physicians), to those in other related medical disciplines, as well as to a wider international readership.
“It is particularly gratifying that a fledgling journal such as PM&R has already been recognized for its contribution to the advancement of physical medicine and rehabilitation,” commented Dr. Weinstein.
“Working in close partnership with the AAPM&R it is our goal to raise the scientific bar and build bridges between practitioners and researchers across this multidisciplinary field. I am thankful to the entire editorial and publishing team who have committed to the success of this journal.”
MEDLINE abstracting and indexing of PM&R will start as soon as possible and will be retroactive to Volume 1/Issue 1. MEDLINE is the U.S. National Library of Medicine’s premier bibliographic database containing over 16 million references to journal articles in life sciences with a concentration on biomedicine. PM&R was evaluated and selected for inclusion based on a stringent review process conducted by the Literature Selection Technical Review Committee, an NIH-chartered advisory committee of external experts. MEDLINE records of PM&R articles will also be accessible via PubMed®.
“Rapid acceptance by MEDLINE clearly acknowledges the high-quality, significant work already published in PM&R and the continuing efforts of the highly-respected editors, reviewers and the Academy. We at Elsevier would like to thank them all for their contribution to this excellent achievement," stated Elsevier’s Herb Niemirow, Publisher of PM&R. Popularly known as the “Purple Journal,” PM&R publishes articles that are contemporary and important to both clinical research and practice. The various sections of the journal highlight original research including clinical trials and observational studies, clinically relevant translational science, comprehensive and focused review articles, case presentations, point/counterpoint discussions and commentary, ethical-legal topics, practice management updates, topical study guides, editorial and opinion pieces, and clinical pearls. Continuing Medical Education opportunities for AMA PRA Category 1 Credit are also offered. PM&R coverage includes acute and chronic musculoskeletal disorders and pain, neurologic conditions involving the central and peripheral nervous systems, rehabilitation of impairments associated with disabilities in adults and children, and neurophysiology and electrodiagnosis.
ABOUT THE AMERICAN ACADEMY OF PHYSICAL MEDICINE AND REHABILITATION (AAPM&R)
Founded in 1938, AAPM&R is the national medical specialty society of more than 7500 physical medicine and rehabilitation (PM&R) physicians, also called physiatrists, who treat patients with musculoskeletal and neurological problems. PM&R physicians care for patients of all ages with acute and chronic pain, peripheral and central nervous system disorders, musculoskeletal injuries including work- and sports-related injuries. They also coordinate the long term rehabilitation process for patients with cancer, amputations and cardiopulmonary diseases. Physiatrists work closely with many other medical specialists and a variety of rehabilitation professionals in areas of psychology, physical and occupational therapy, and vocational rehabilitation.
About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier’s 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect, MD Consult, Scopus, bibliographic databases, and online reference works.

Elsevier is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group, a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange.

Media Contact:
Ylann Schemm
Corporate Relations, Elsevier
Newsroom@elsevier.com
+31 20 485 2025

Amsterdam, 29 June 2009 – Elsevier, the leading publisher of scientific, technical and medical information products and services, today announced the highlights of its journal impact factor performance in 2008. Elsevier overall saw 75% of its journal impact factors (IF) increase from 2007 to 2008. According to the 2008 Journal Citation Report® published by ThomsonReuters, Elsevier journals took the #1 position in 51 categories (of 229 in total) across all of the sciences and social sciences.
In addition, 30 Elsevier journals got their first IF this year. Some of these journals received very impressive scores including two Cell Press journals:   Cell Stem Cell (16.826) entered the Cell Biology category ranked 6th (of 157 journals), while   Cell Host & Microbe (7.436) entered the Microbiology category ranked10th (of 91 journals). Another impressive result in its first year is   Materials Today (12.929), which is ranked 4th in the Materials Science, Multidisciplinary category (of 191 journals).
This year there were 182 Elsevier journals that increased their IF by more than 50% over their 2007 scores. All three The Lancet speciality journals improved their IF this year.   The Lancet Infectious Diseases increased to 13.165, placing it at the #1 position in the Infectious Diseases category.   The Lancet Oncology (http://www.thelancet.com/journals/lanonc/issue/current) rose to 13.283, an increase of over 1 full IF point from the 2007 IF. Finally,   The Lancet Neurology increased by 40% to 14.270, thereby retaining the #1 position in the Clinical Neurology category for the 5th year running.
Other Elsevier journals continue their long-running trend of increased IFs, in particular   Biomaterials (increasing yearly since 2003) and   The Journal of Allergy and Clinical Immunology which has shown consistent growth over the past five years.
Glen Campbell, Senior Vice President of U.S. Health Sciences Journals said, "Each annual announcement of impact factors confirms the depth and excellence of our health sciences journal publishing program. The superior performance of so many of our journals this year is a sign of the strong partnerships we have with our journal editors and our societies. This year's impact factor growth is one indication of the hard work and focus on quality of these collaborations."
“The fact that Elsevier’s overall results are amongst the best in the industry is a true indication of the impact of the increased focus on quality we have placed on our journals in the past three years. The increased impact factors, across the board, are evidence that the research we publish is of the highest quality,” remarked Martin Tanke, Managing Director of Science and Technology Journals. “We are grateful for our strong network of editors we partner with, who work with us each day to build our journals to some of the best in their fields.”
The impact factor is a measure of the frequency with which the average article in a journal has been cited in a particular year. The impact factor helps to evaluate a journal’s relative importance, especially when compared with others in the same field.
About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier’s 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect, MD Consult, Scopus, bibliographic databases, and online reference works.

Elsevier is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group, a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange.

Media Contact:
Ylann Schemm
Corporate Relations, Elsevier
Newsroom@elsevier.com
+31 20 485 2025

SLA Centennial Observance Honors Cell, The Lancet and other key Elsevier journals

Amsterdam, April 6th 2009 – Twenty journals published by Elsevier (many on behalf of renowned societies) have been nominated for the Special Library Association’s (SLA) Top 100 Journals in Biology and Medicine. The Top 100 list is compiled by the 680-plus members of the Biomedical and Life Sciences Division (DBIO) on the most influential journals in biology and medicine over the last 100 years. The “Journal of the Century” and the winners of this prestigious award will be announced on Tuesday, June 16th, at the Centennial Conference of the Special Libraries Association in Washington DC.
 
Established in 1909 to serve librarians specialized in business, government, social agencies, and academia, the SLA is now an 11,000-member professional organization of subject specialist librarians, information managers, and publishing industry representatives. Each topical division has contributed a Centennial-themed event throughout the year. In 2008, DBIO convened an international panel of nine eminent subject experts to compile a ballot for an electronic poll of SLA members concerning the 100 most influential journals of biology and medicine over the past century of SLA’s existence.

"We are tremendously honored and proud to have so many journals and society partners recognized for excellence by the SLA's community of information pioneers," remarked Youngsuk "Y.S." Chi, Vice Chairman at Elsevier, who will attend the June 16th award ceremony. "All of the journals that are on this list are outstanding, reflecting a thriving and fiercely competitive biomedical and life sciences research community and the publishing community's support that is driven to advance scientific discovery."

The DBIO 100, the 100 Most Influential Journals in Biology & Medicine over the last 100 Years as voted by the BioMedical & Life Sciences Division of the Special Libraries Association on the Occasion of its Centennial include 20 Elsevier journals, many published in partnership with prestigious societies:

• The American Journal of Human Genetics, Cell Press with the American Society of Human Genetics
• American Journal of Obstetrics & Gynecology, Elsevier with the American
• Gynecological and Obstetrical Society
  
• Animal Behaviour, Elsevier with the Association for the Study of Animal Behaviour, UK, and the Animal Behavior Society, US
• Annals of Emergency Medicine, Elsevier with the American College of Emergency Physicians
• Archives of Physical Medicine and Rehabilitation, Elsevier with the American Congress of Rehabilitation
• Biochimica et Biophysica Acta, Elsevier
• Brain and Cognition, Elsevier together with several US and international cognitive neuropsychology societies
• Cell, Cell Press, Elsevier
• Current Biology, Cell Press, Elsevier
• Developmental Biology, Elsevier with the Society for Developmental Biology
• Gastroenterology, Elsevier with the American Gastroenterological Association
• The Journal of Allergy and Clinical Immunology, Elsevier with the American Academy of Allergy, Asthma and Immunology
• Journal of Experimental Marine Biology and Ecology, Elsevier
• Journal of Human Evolution,Elsevier
• Journal of Molecular Biology, Elsevier
• Journal of the American Academy of Dermatology, Elsevier with the American Academy of Dermatology
• Journal of the American College of Surgeons, Elsevier with the American College of Surgeons
• The Journal of Urology, Elsevier with the American Urological Association
• The Lancet, Elsevier
• Virology, Elsevier

About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier’s 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect, MD Consult, Scopus, bibliographic databases, and online reference works.

Elsevier is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group, a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange.